NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Law & Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law & Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Law Offices of Howard G. Smith



Law Offices of Howard G. Smith Announces Class Action Lawsuit Against GPC Biotech



August 18th, 2007

Law Offices of Howard G. Smith announces that a securities class action lawsuit has been filed on behalf of shareholders who purchased the securities of GPC Biotech AG ("GPC Biotech" or the "Company")(NASDAQ:GPCB) between December 5, 2005 and July 24, 2007, inclusive (the "Class Period"). The class action lawsuit was filed in the United States District Court for the Southern District of New York.

The Complaint alleges that defendants violated federal securities laws by issuing material misrepresentations to the market concerning the prospects for U.S. Food & Drug Administration approval of Satraplatin -- a treatment for advanced prostate cancer -- thereby artificially...


Source: Law & Health Weekly (2007-08-18)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login